PharmaBoardroom

Interview: Mehmet Pisak – CEO, Imuneks Farma – Turkey

Imuneks is currently operating in the OTC market, but with three supergeneric products ready to market on the RX side, the firm has the potential to…

Interview: Ignacio Pino – President, CDI Laboratories Inc.…

Ignacio Pino, president of CDI Laboratories Inc., discusses how his novel technology platform Hu-Prot will help pharmaceutical companies and academia…

Interview: Antonio Medina Comas – Executive Director, PRIDCO…

The Puerto Rico Industrial Development Company (PRIDCO) is a government agency underneath the Puerto Rican Department of Economic Development and…

Interview: Melinda Badenhorst – General Manager, Novagen Pharma…

The general manager of Novagen Pharma reveals how they are the second largest supplier of ARVs within the private South African market, how there is…

Guillaume Drianno – General Manager, Servier Thailand

Servier Thailand’s general manager discusses the company’s competitive role in Thailand despite market challenges, the company’s ability to…

Interview: Yongvut Saovapruk, Governor – Thailand Institute of…

The Thailand Institute of Scientific and Technological Research’s (TISTR) governor shares the institute’s role in facilitating R&D, the use of…

Interview: Ismail Yormaz – VP and Regional Director South…

Recordati’s South East regional VP, based in Istanbul, discusses Recordati Turkey’s key role as a manufacturing hub for Recordati, the importance…

Interview: Filiz Balcay – General Manager, Chiesi Turkey

Turkey is quickly becoming a regional hub for pharmaceutical industry for management, clinical trials and manufacturing, explains the general manager…

Interview: Onder Isinay – General Manager, Biocodex Turkey

Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better…

Interview: Ilker Özbay – General Manager, Daiichi Sankyo…

The general manager of Daiichi Sankyo Turkey discusses his affiliate's expansion into a regional hub, current strategies for growth in the Turkish…

Seoul’s Global Competitiveness In Clinical Trials

The following table shows how Seoul has risen through the ranks of cities around the world to become the most competitive city for clinical trials of…

Korea’s Pharmaceutical Spending Compared To OECD Average,…

As the following graph shows, Korea's annual growth of pharma spending in real terms dropped ahead of the rest of the OECD.

Tagged with